VivaWell and Keyzell Holding Announce Strategic Global Cooperation to Develop Innovative AI Health Solutions

VivaWell, the healthtech innovator in Mexico and Argentina, has announced a strategic global cooperation with Keyzell Holding, a leader in biotech precision medicine. This collaboration aims to accelerate the integration of advanced technological solutions in the healthcare sector worldwide.

Through this partnership, VivaWell and Keyzell will focus on integrating AI technologies in health monitoring and developing personalized treatments. This cooperation will provide access to new health solutions combining holistic well-being and specific treatments for serious illnesses, expanding the reach of precision medicine.

Eduardo Iglesias, Founder and CEO of VivaWell, stated, "We are excited about this collaboration that enhances our technological capabilities and our commitment to improving health. Keyzell Holding's leadership in AI biotech will allow us to offer more advanced solutions."

José del Corral, CEO of Keyzell Holding, highlighted the strategic opportunity this collaboration brings in expanding their global impact in biotechnology. Their focus will be on leveraging technological innovations to address complex medical challenges, thus improving the lives of thousands.

This agreement underscores the shared commitment of both companies to revolutionize the healthcare sector through advanced, personalized treatments aligned with the latest research and advancements in global biotechnology.